BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
HIV infection
,
Embryo
,
Pharmacogenetics
,
Fenofibrate
,
rs6983267
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
La protein, RNA-binding domain
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Nipple cross-section
Fallopian tube
Vulva
Uterus
Fetal brain
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hemorrhagic shock
Disorder of uterus
Lyme disease
Vesicular stomatitis Indiana virus disease
Cerebral palsy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Antigens, Neoplasm
Gramicidin
Inosine
BMP6 protein, human
Graphene
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
Ptger4
RPL35
PPIC
PICALM
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Estrogen-dendrimer conjugate and estrogen treated MCF-7 cells
Medulloblastomas and primitive neuroectodermal tumors
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Diffuse large B-cell lymphoma HLY1 cells overexpressing elF4E1 or eIF4E3
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for La protein, RNA-binding domain
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir a…
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plu…
ACE2 Gender Differences in Stroke With COVID-19
A Study of BAX 888 in Male Adults With Severe Hemophilia A
Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodefi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ